世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

Stroke Treatment Market (Type: Ischemic Stroke and Hemorrhagic Stroke; Drug Class: Anticoagulants, Antiplatelets, Tissue plasminogen activator (tPA), Statins, Beta-Blockers, Others; Route of Administration: Oral and Parenteral; Drug Availability: Branded and Generic and Distribution Channel: Hospital Pharmacies, Online Pharmacies and Retail Pharmacies) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025-2035

Stroke Treatment Market (Type: Ischemic Stroke and Hemorrhagic Stroke; Drug Class: Anticoagulants, Antiplatelets, Tissue plasminogen activator (tPA), Statins, Beta-Blockers, Others; Route of Administration: Oral and Parenteral; Drug Availability: Branded and Generic and Distribution Channel: Hospital Pharmacies, Online Pharmacies and Retail Pharmacies) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025-2035


Stroke Treatment Market – Scope of Report TMR’s report on the global stroke treatment market studies the past as well as the current growth trends and opportunities to gain valuable insights of th... もっと見る

 

 

出版社 出版年月 電子版価格 納期 ページ数 言語
Transparency Market Research
トランスペアレンシーマーケットリサーチ
2025年3月26日 US$5,795
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら
3-5営業日程度 165 英語

英語原文をAIを使って翻訳しています。


 

Summary

Stroke Treatment Market – Scope of Report
TMR’s report on the global stroke treatment market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2025 to 2035. The report provides revenue of the global stroke treatment market for the period 2019–2035, considering 2025 as the base year and 2035 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global stroke treatment market from 2025 to 2035.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the stroke treatment market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global stroke treatment market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global stroke treatment market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global stroke treatment market.

The report delves into the competitive landscape of the global stroke treatment market. Key players operating in the global stroke treatment market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global stroke treatment market profiled in this report.

Key Questions Answered in Global stroke treatment Market Report
• What is the sales/revenue generated by stroke treatment across all regions during the forecast period?
• What are the opportunities in the global stroke treatment market?
• What are the major drivers, restraints, opportunities, and threats in the market?
• Which regional market is set to expand at the fastest CAGR during the forecast period?
• Which segment is expected to generate the highest revenue globally in 2035?
• Which segment is projected to expand at the highest CAGR during the forecast period?
• What are the market positions of different companies operating in the global market?

Stroke Treatment Market – Research Objectives and Research Approach
The comprehensive report on the global stroke treatment market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global stroke treatment market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2035 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global stroke treatment market.


ページTOPに戻る


Table of Contents

1. Preface
    1.1. Market Definition and Scope
    1.2. Market Segmentation
    1.3. Key Research Objectives
    1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Stroke Treatment Market
4. Market Overview
    4.1. Introduction
        4.1.1. Segment Definition
    4.2. Overview
    4.3. Market Dynamics
        4.3.1. Drivers
        4.3.2. Restraints
        4.3.3. Opportunities
    4.4. Global Stroke Treatment Market Analysis and Forecast, 2020-2035
        4.4.1. Market Revenue Projections (US$ Bn)
5. Key Insights
    5.1. Key Industry Events
    5.2. PESTEL Analysis
    5.3. Regulatory Scenario by Key Countries/Regions
    5.4. PORTER’s Five Forces Analysis
    5.5. Product/Brand Analysis
    5.6. Supply Chain Analysis
    5.7. Pipeline Analysis
6. Global Stroke Treatment Market Analysis and Forecast, by Type
    6.1. Introduction & Definition
    6.2. Key Findings/Developments
    6.3. Market Value Forecast, by Type, 2020-2035
        6.3.1. Ischemic Stroke
            6.3.1.1. Thrombotic Stroke
            6.3.1.2. Embolic Stroke
        6.3.2. Hemorrhagic Stroke
            6.3.2.1. Intracerebral Hemorrhage
            6.3.2.2. Subarachnoid Hemorrhage
    6.4. Market Attractiveness Analysis, by Type
7. Global Stroke Treatment Market Analysis and Forecast, by Drug Class
    7.1. Introduction & Definition
    7.2. Key Findings/Developments
    7.3. Market Value Forecast, by Drug Class, 2020-2035
        7.3.1. Anticoagulants
        7.3.2. Antiplatelets
        7.3.3. Tissue plasminogen activator (tPA)
        7.3.4. Statins
        7.3.5. Beta-Blockers
        7.3.6. Others
    7.4. Market Attractiveness Analysis, by Drug Class
8. Global Stroke Treatment Market Analysis and Forecast, by Route of Administration
    8.1. Introduction & Definition
    8.2. Key Findings/Developments
    8.3. Market Value Forecast, by Route of Administration, 2020-2035
        8.3.1. Oral
        8.3.2. Parenteral
    8.4. Market Attractiveness Analysis, by Route of Administration
9. Global Stroke Treatment Market Analysis and Forecast, by Drug Availability
    9.1. Introduction & Definition
    9.2. Key Findings/Developments
    9.3. Market Value Forecast, by Drug Availability, 2020-2035
        9.3.1. Branded
        9.3.2. Generic
    9.4. Market Attractiveness Analysis, by Drug Availability
10. Global Stroke Treatment Market Analysis and Forecast, by Distribution Channel
    10.1. Introduction & Definition
    10.2. Key Findings/Developments
    10.3. Market Value Forecast, by Distribution Channel, 2020-2035
        10.3.1. Hospital Pharmacies
        10.3.2. Retail Pharmacies
        10.3.3. Online Pharmacies
    10.4. Market Attractiveness Analysis, by Distribution Channel
11. Global Stroke Treatment Market Analysis and Forecast, by Region
    11.1. Key Findings
    11.2. Market Value Forecast, by Region, 2020-2035
        11.2.1. North America
        11.2.2. Europe
        11.2.3. Asia Pacific
        11.2.4. Latin America
        11.2.5. Middle East & Africa
    11.3. Market Attractiveness Analysis, by Region
12. North America Stroke Treatment Market Analysis and Forecast
    12.1. Introduction
        12.1.1. Key Findings
    12.2. Market Value Forecast, by Type, 2020-2035
        12.2.1. Ischemic Stroke
            12.2.1.1. Thrombotic Stroke
            12.2.1.2. Embolic Stroke
        12.2.2. Hemorrhagic Stroke
            12.2.2.1. Intracerebral Hemorrhage
            12.2.2.2. Subarachnoid Hemorrhage
    12.3. Market Value Forecast, by Drug Class, 2020-2035
        12.3.1. Anticoagulants
        12.3.2. Antiplatelets
        12.3.3. Tissue plasminogen activator (tPA)
        12.3.4. Statins
        12.3.5. Beta-Blockers
        12.3.6. Others
    12.4. Market Value Forecast, by Route of Administration, 2020-2035
        12.4.1. Oral
        12.4.2. Parenteral
    12.5. Market Value Forecast, by Drug Availability, 2020-2035
        12.5.1. Branded
        12.5.2. Generic
    12.6. Market Value Forecast, by Distribution Channel, 2020-2035
        12.6.1. Hospital Pharmacies
        12.6.2. Retail Pharmacies
        12.6.3. Online Pharmacies
    12.7. Market Value Forecast, by Country, 2020-2035
        12.7.1. U.S.
        12.7.2. Canada
    12.8. Market Attractiveness Analysis
        12.8.1. By Type
        12.8.2. By Drug Class
        12.8.3. By Route of Administration
        12.8.4. By Drug Availability
        12.8.5. By Distribution Channel
        12.8.6. By Country
13. Europe Stroke Treatment Market Analysis and Forecast
    13.1. Introduction
        13.1.1. Key Findings
    13.2. Market Value Forecast, by Type, 2020-2035
        13.2.1. Ischemic Stroke
            13.2.1.1. Thrombotic Stroke
            13.2.1.2. Embolic Stroke
        13.2.2. Hemorrhagic Stroke
            13.2.2.1. Intracerebral Hemorrhage
            13.2.2.2. Subarachnoid Hemorrhage
    13.3. Market Value Forecast, by Drug Class, 2020-2035
        13.3.1. Anticoagulants
        13.3.2. Antiplatelets
        13.3.3. Tissue plasminogen activator (tPA)
        13.3.4. Statins
        13.3.5. Beta-Blockers
        13.3.6. Others
    13.4. Market Value Forecast, by Route of Administration, 2020-2035
        13.4.1. Oral
        13.4.2. Parenteral
    13.5. Market Value Forecast, by Drug Availability, 2020-2035
        13.5.1. Branded
        13.5.2. Generic
    13.6. Market Value Forecast, by Distribution Channel, 2020-2035
        13.6.1. Hospital Pharmacies
        13.6.2. Retail Pharmacies
        13.6.3. Online Pharmacies
    13.7. Market Value Forecast, by Country/Sub-region, 2020-2035
        13.7.1. Germany
        13.7.2. UK
        13.7.3. France
        13.7.4. Italy
        13.7.5. Spain
        13.7.6. Rest of Europe
    13.8. Market Attractiveness Analysis
        13.8.1. By Type
        13.8.2. By Drug Class
        13.8.3. By Route of Administration
        13.8.4. By Drug Availability
        13.8.5. By Distribution Channel
        13.8.6. By Country/Sub-region

ページTOPに戻る



List of Tables/Graphs

List of Figures

Figure 01: Global Stroke Treatment Market Value (US$ Bn) Forecast, 2020-2035

Figure 02: Global Stroke Treatment Market Value Share Analysis, By Type, 2024 and 2035

Figure 03: Global Stroke Treatment Market Attractiveness Analysis, By Type, 2025-2035

Figure 04: Global Stroke Treatment Market Revenue (US$ Bn), by Ischemic Stroke, 2020-2035

Figure 05: Global Stroke Treatment Market Value Share Analysis, By Drug Class, 2024 and 2035

Figure 06: Global Stroke Treatment Market Attractiveness Analysis, By Drug Class, 2025-2035

Figure 07: Global Stroke Treatment Market Revenue (US$ Bn), by Anticoagulants, 2020-2035

Figure 08: Global Stroke Treatment Market Revenue (US$ Bn), by Antiplatelets, 2020-2035

Figure 09: Global Stroke Treatment Market Revenue (US$ Bn), by Tissue plasminogen activator (tPA), 2020-2035

Figure 10: Global Stroke Treatment Market Revenue (US$ Bn), by Statins, 2020-2035

Figure 11: Global Stroke Treatment Market Revenue (US$ Bn), by Beta-Blockers, 2020-2035

Figure 12: Global Stroke Treatment Market Revenue (US$ Bn), by Others, 2020-2035

Figure 13: Global Stroke Treatment Market Value Share Analysis, By Route of Administration, 2024 and 2035

Figure 14: Global Stroke Treatment Market Attractiveness Analysis, By Route of Administration, 2025-2035

Figure 15: Global Stroke Treatment Market Revenue (US$ Bn), by Oral, 2020-2035

Figure 16: Global Stroke Treatment Market Revenue (US$ Bn), by Parenteral, 2020-2035

Figure 17: Global Stroke Treatment Market Value Share Analysis, By Drug Availability, 2024 and 2035

Figure 18: Global Stroke Treatment Market Attractiveness Analysis, By Drug Availability, 2025-2035

Figure 19: Global Stroke Treatment Market Revenue (US$ Bn), by Branded, 2020-2035

Figure 20: Global Stroke Treatment Market Revenue (US$ Bn), by Generic, 2020-2035

Figure 21: Global Stroke Treatment Market Value Share Analysis, By Distribution Channel, 2024 and 2035

Figure 22: Global Stroke Treatment Market Attractiveness Analysis, By Distribution Channel, 2025-2035

Figure 23: Global Stroke Treatment Market Revenue (US$ Bn), by Hospital Pharmacies, 2020-2035

Figure 24: Global Stroke Treatment Market Revenue (US$ Bn), by Retail Pharmacies, 2020-2035

Figure 25: Global Stroke Treatment Market Revenue (US$ Bn), by Online Pharmacies, 2020-2035

Figure 26: Global Stroke Treatment Market Value Share Analysis, By Region, 2024 and 2035

Figure 27: Global Stroke Treatment Market Attractiveness Analysis, By Region, 2025-2035

Figure 28: North America - Stroke Treatment Market Value (US$ Bn) Forecast, 2020-2035

Figure 29: North America - Stroke Treatment Market Value Share Analysis, by Country, 2024 and 2035

Figure 30: North America - Stroke Treatment Market Attractiveness Analysis, by Country, 2025-2035

Figure 31: North America - Stroke Treatment Market Value Share Analysis, By Type, 2024 and 2035

Figure 32: North America - Stroke Treatment Market Attractiveness Analysis, By Type, 2025-2035

Figure 33: North America - Stroke Treatment Market Value Share Analysis, By Drug Class, 2024 and 2035

Figure 34: North America - Stroke Treatment Market Attractiveness Analysis, By Drug Class, 2025-2035

Figure 35: North America - Stroke Treatment Market Value Share Analysis, By Route of Administration, 2024 and 2035

Figure 36: North America - Stroke Treatment Market Attractiveness Analysis, By Route of Administration, 2025-2035

Figure 37: North America - Stroke Treatment Market Value Share Analysis, By Drug Availability, 2024 and 2035

Figure 38: North America - Stroke Treatment Market Attractiveness Analysis, By Drug Availability, 2025-2035

Figure 39: North America - Stroke Treatment Market Value Share Analysis, By Distribution Channel, 2024 and 2035

Figure 40: North America - Stroke Treatment Market Attractiveness Analysis, By Distribution Channel, 2025-2035

Figure 41: Europe - Stroke Treatment Market Value (US$ Bn) Forecast, 2020-2035

Figure 42: Europe - Stroke Treatment Market Value Share Analysis, by Country / Sub-region, 2024 and 2035

Figure 43: Europe - Stroke Treatment Market Attractiveness Analysis, by Country / Sub-region, 2025-2035

Figure 44: Europe - Stroke Treatment Market Value Share Analysis, By Type, 2024 and 2035

Figure 45: Europe - Stroke Treatment Market Attractiveness Analysis, By Type, 2025-2035

Figure 46: Europe - Stroke Treatment Market Value Share Analysis, By Drug Class, 2024 and 2035

Figure 47: Europe - Stroke Treatment Market Attractiveness Analysis, By Drug Class, 2025-2035

Figure 48: Europe - Stroke Treatment Market Value Share Analysis, By Route of Administration, 2024 and 2035

Figure 49: Europe - Stroke Treatment Market Attractiveness Analysis, By Route of Administration, 2025-2035

Figure 50: Europe - Stroke Treatment Market Value Share Analysis, By Drug Availability, 2024 and 2035

Figure 51: Europe - Stroke Treatment Market Attractiveness Analysis, By Drug Availability, 2025-2035

Figure 52: Europe - Stroke Treatment Market Value Share Analysis, By Distribution Channel, 2024 and 2035

Figure 53: Europe - Stroke Treatment Market Attractiveness Analysis, By Distribution Channel, 2025-2035

Figure 54: Asia Pacific - Stroke Treatment Market Value (US$ Bn) Forecast, 2020-2035

Figure 55: Asia Pacific - Stroke Treatment Market Value Share Analysis, by Country/Sub-region, 2024 and 2035

Figure 56: Asia Pacific - Stroke Treatment Market Attractiveness Analysis, by Country/Sub-region, 2025-2035

Figure 57: Asia Pacific - Stroke Treatment Market Value Share Analysis, By Type, 2024 and 2035

Figure 58: Asia Pacific - Stroke Treatment Market Attractiveness Analysis, By Type, 2025-2035

Figure 59: Asia Pacific - Stroke Treatment Market Value Share Analysis, By Drug Class, 2024 and 2035

Figure 60: Asia Pacific - Stroke Treatment Market Attractiveness Analysis, By Drug Class, 2025-2035

Figure 61: Asia Pacific - Stroke Treatment Market Value Share Analysis, By Route of Administration, 2024 and 2035

Figure 62: Asia Pacific - Stroke Treatment Market Attractiveness Analysis, By Route of Administration, 2025-2035

Figure 63: Asia Pacific - Stroke Treatment Market Value Share Analysis, By Drug Availability, 2024 and 2035

Figure 64: Asia Pacific - Stroke Treatment Market Attractiveness Analysis, By Drug Availability, 2025-2035

Figure 65: Asia Pacific - Stroke Treatment Market Value Share Analysis, By Distribution Channel, 2024 and 2035

Figure 66: Asia Pacific - Stroke Treatment Market Attractiveness Analysis, By Distribution Channel, 2025-2035

Figure 67: Latin America - Stroke Treatment Market Value (US$ Bn) Forecast, 2020-2035

Figure 68: Latin America - Stroke Treatment Market Value Share Analysis, by Country / Sub-region, 2024 and 2035

Figure 69: Latin America - Stroke Treatment Market Attractiveness Analysis, by Country / Sub-region, 2025-2035

Figure 70: Latin America - Stroke Treatment Market Value Share Analysis, By Type, 2024 and 2035

Figure 71: Latin America - Stroke Treatment Market Attractiveness Analysis, By Type, 2025-2035

Figure 72: Latin America - Stroke Treatment Market Value Share Analysis, By Drug Class, 2024 and 2035

Figure 73: Latin America - Stroke Treatment Market Attractiveness Analysis, By Drug Class, 2025-2035

Figure 74: Latin America - Stroke Treatment Market Value Share Analysis, By Route of Administration, 2024 and 2035

Figure 75: Latin America - Stroke Treatment Market Attractiveness Analysis, By Route of Administration, 2025-2035

Figure 76: Latin America - Stroke Treatment Market Value Share Analysis, By Drug Availability, 2024 and 2035

Figure 77: Latin America - Stroke Treatment Market Attractiveness Analysis, By Drug Availability, 2025-2035

Figure 78: Latin America - Stroke Treatment Market Value Share Analysis, By Distribution Channel, 2024 and 2035

Figure 79: Latin America - Stroke Treatment Market Attractiveness Analysis, By Distribution Channel, 2025-2035

Figure 80: Middle East & Africa - Stroke Treatment Market Value (US$ Bn) Forecast, 2020-2035

Figure 81: Middle East & Africa - Stroke Treatment Market Value Share Analysis, by Country / Sub-region, 2024 and 2035

Figure 82: Middle East & Africa - Stroke Treatment Market Attractiveness Analysis, by Country / Sub-region, 2025-2035

Figure 83: Middle East & Africa - Stroke Treatment Market Value Share Analysis, By Type, 2024 and 2035

Figure 84: Middle East & Africa - Stroke Treatment Market Attractiveness Analysis, By Type, 2025-2035

Figure 85: Middle East & Africa - Stroke Treatment Market Value Share Analysis, By Drug Class, 2024 and 2035

Figure 86: Middle East & Africa - Stroke Treatment Market Attractiveness Analysis, By Drug Class, 2025-2035

Figure 87: Middle East & Africa - Stroke Treatment Market Value Share Analysis, By Route of Administration, 2024 and 2035

Figure 88: Middle East & Africa - Stroke Treatment Market Attractiveness Analysis, By Route of Administration, 2025-2035

Figure 89: Middle East & Africa - Stroke Treatment Market Value Share Analysis, By Drug Availability, 2024 and 2035

Figure 90: Middle East & Africa - Stroke Treatment Market Attractiveness Analysis, By Drug Availability, 2025-2035

Figure 91: Middle East & Africa - Stroke Treatment Market Value Share Analysis, By Distribution Channel, 2024 and 2035

Figure 92: Middle East & Africa - Stroke Treatment Market Attractiveness Analysis, By Distribution Channel, 2025-2035

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野(医薬)の最新刊レポート

Transparency Market Research社の製薬分野での最新刊レポート

本レポートと同じKEY WORD(drug)の最新刊レポート


よくあるご質問


Transparency Market Research社はどのような調査会社ですか?


トレンスペアレンシーマーケットリサーチ(Transparency Market Research /TMR)は市場参入やホワイトスペースの特定、新商品や新サービスの立ち上げ、戦略的M&Aなどの実現のた... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2025/06/17 10:26

146.08 円

169.07 円

200.84 円

ページTOPに戻る